Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.103x

Based on the latest financial reports, Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a cash flow conversion efficiency ratio of 0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥670.83 Million ≈ $98.16 Million USD) by net assets (CN¥6.50 Billion ≈ $950.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Shanghai Allist Pharmaceuticals Co. Ltd. for the company's overall valuation and market capitalisation.

Shanghai Allist Pharmaceuticals Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Shanghai Allist Pharmaceuticals Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Allist Pharmaceuticals Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Allist Pharmaceuticals Co. Ltd. A ranked by their cash flow conversion efficiency. Explore earnings quality score of Shanghai Allist Pharmaceuticals Co. Ltd. to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Grupo Aeroportuario del Sureste S. A. B. de C. V MX:ASURB	0.075x
Tencent Music Entertainment Group F:63TA	0.030x
STAG Industrial Inc NYSE:STAG	0.041x
Immunovant Inc NASDAQ:IMVT	-0.169x
Yanzhou Coal Mining Company Limited F:YZC	0.000x
Alkermes Plc NASDAQ:ALKS	0.080x
Conagra Brands, Inc. NYSE:CAG	0.080x
JUSUNG ENGINEERING Co. Ltd KQ:036930	-0.027x

Annual Cash Flow Conversion Efficiency for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2025. View Shanghai Allist Pharmaceuticals Co. Ltd. share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥14.40 Billion ≈ $2.11 Billion	CN¥2.32 Billion ≈ $339.86 Million	0.161x	-45.60%
2024-12-31	CN¥5.28 Billion ≈ $773.04 Million	CN¥1.57 Billion ≈ $229.16 Million	0.296x	+74.98%
2023-12-31	CN¥3.98 Billion ≈ $582.73 Million	CN¥674.65 Million ≈ $98.72 Million	0.169x	+489.25%
2022-12-31	CN¥3.19 Billion ≈ $466.37 Million	CN¥91.63 Million ≈ $13.41 Million	0.029x	+191.84%
2021-12-31	CN¥2.97 Billion ≈ $435.08 Million	CN¥29.29 Million ≈ $4.29 Million	0.010x	+114.41%
2020-12-31	CN¥2.88 Billion ≈ $421.15 Million	CN¥-196.75 Million ≈ $-28.79 Million	-0.068x	+68.78%
2019-12-31	CN¥1.18 Billion ≈ $173.31 Million	CN¥-259.37 Million ≈ $-37.95 Million	-0.219x	+84.00%
2018-12-31	CN¥71.04 Million ≈ $10.39 Million	CN¥-97.25 Million ≈ $-14.23 Million	-1.369x	-5261.91%
2017-12-31	CN¥381.26 Million ≈ $55.79 Million	CN¥10.11 Million ≈ $1.48 Million	0.027x	--

About Shanghai Allist Pharmaceuticals Co. Ltd. A

SHG:688578 China Biotechnology

Market Cap

$6.86 Billion

CN¥46.90 Billion CNY

Market Cap Rank

#2916 Global

#360 in China

Share Price

CN¥104.22

Change (1 day)

-7.29%

52-Week Range

CN¥80.02 - CN¥133.00

All Time High

CN¥133.00